Wiley has further expanded its KnowItAll Raman Spectral Library collection, bringing the collection to over 27,000 spectra. The addition of new data to the collections underscores Wiley’s continuing commitment to provide analytical data to increase lab efficiency and throughput. Subscribers automatically gain access to the new data, ensuring they always have the most up-to-date information [...]

The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications. Morrisville, NC / Berkeley, CA -- SynOligo Biotechnologies Inc. and Lumiphore Inc. announced they have entered into a partnership to incorporate Lumiphore’s luminescent lanthanide reporter technology conjugated to SynOligo’s oligonucleotide offerings for diagnostic tests and use in life [...]

FOSTER CITY, Calif. -- Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced today an Illumina-sponsored grant for Early Access to Illumina Protein Prep 9.5K™. Powered by SOMAmer® technology, this next-generation sequencing (NGS)-based platform enables comprehensive proteomic profiling of plasma and serum. Illumina Protein Prep 9.5K™ utilizes slow [...]

Appoints new CEO and VP of Commercial to drive commercial expansion and portfolio strategy HOLLISTON, Mass. – Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, today announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company’s ability to broaden [...]

Introducing Cheetah™ FLEX and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerases for qPCR, PEA, and NGS-Based PEA Workflows FREMONT, CA -- Biotium, a leading provider of fluorescent reagents for life science research, proudly expands its trusted Cheetah™ Taq DNA Polymerase line with two new formulations: Cheetah™ FLEX HotStart Taq DNA Polymerase and  Cheetah™ PEA-PLEX HotStart Taq DNA Polymerase. These optimized [...]

Empowering biopharma with seamless, high-precision workflows from biomarker discovery to targeted enrichment and protein quantification for clinical trials  WASHINGTON, D.C. and ZUERICH, Switzerland – SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, today announced an exclusive strategic collaboration to offer biopharma customers a streamlined end-to-end solution for high-sensitivity [...]

Tesela Copilot Accelerates R&D, Fully Embedded in TeselaGen’s Cutting-Edge ELN and Platform PORTOLA VALLEY, Calif. –  TeselaGen, a leading provider of AI-augmented design and automation software for biotechnology, announced the recent alpha release of its powerful agentic Copilot, seamlessly integrated with TeselaGen’s Platform for Biological R&D. This breakthrough solution harnesses advanced artificial intelligence to streamline [...]

Empowering biopharma with seamless, high-precision workflows from biomarker discovery to targeted enrichment and protein quantification for clinical trials WASHINGTON and ZURICH -- SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, today announced an exclusive strategic collaboration to offer biopharma customers a streamlined end-to-end solution for high-sensitivity [...]

Morpho Biotech announces it has signed a distribution agreement with MACHEREY-NAGEL (MN) to distribute their Bioanalysis portfolio in the Netherlands as of July 1st. MN is an innovative international company for chemical and biomolecular analysis. The Bioanalysis portfolio of MN consists of efficient and reliable kits for RNA, DNA and protein purification from various sample [...]

Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea -- Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over [...]